Progesterone, Lipoic Acid, and Sulforaphane as Promising Antioxidants for Retinal Diseases: A Review

Autor: Inmaculada Almansa, Vicente Hernández-Rabaza, Rosa López-Pedrajas
Přispěvatelé: UCH. Departamento de Ciencias Biomédicas, Producción Científica UCH 2019
Rok vydání: 2019
Předmět:
0301 basic medicine
Antioxidant
Physiology
medicine.medical_treatment
Clinical Biochemistry
sulforaphane
Review
Pharmacology
Progesterona - Uso terapéutico
medicine.disease_cause
Biochemistry
chemistry.chemical_compound
0302 clinical medicine
Retina - Diseases - Risk factors
Ácido lipoico - Uso terapéutico
reactive oxygen species
Sulforaphane - Therapeutic use
Retina - Diseases - Treatment
Lipoic acid
retinal diseases
antioxidants
Antioxidantes
macular degeneration
progesterone
Neuroprotection
Progesterone - Therapeutic use
03 medical and health sciences
retinitis pigmentosa
Retinitis pigmentosa
medicine
Retina - Enfermedades - Factores de riesgo
Molecular Biology
business.industry
lcsh:RM1-950
Retinal
Cell Biology
Macular degeneration
medicine.disease
lipoic acid
Lipoic acid - Therapeutic use
030104 developmental biology
lcsh:Therapeutics. Pharmacology
chemistry
030221 ophthalmology & optometry
business
Antioxidants
diabetes retinopathy
Sulforafano - Uso terapéutico
Oxidative stress
Sulforaphane
Retina - Enfermedades - Tratamiento
Zdroj: Antioxidants
Antioxidants, Vol 8, Iss 3, p 53 (2019)
CEU Repositorio Institucional
Fundación Universitaria San Pablo CEU (FUSPCEU)
ISSN: 2076-3921
Popis: Este artículo se ha publicado de forma definitiva en: https://www.mdpi.com/2076-3921/8/3/53 Este artículo pertenece al número especial "Antioxidants and Retinal Disease". Oxidative stress has been documented to be a key factor in the cause and progression of different retinal diseases. Oxidative cellular unbalance triggers a sequence of reactions which prompt cell degeneration and retinal dysfunction, both hallmarks of several retinal pathologies. There is no effective treatment, yet, for many retinal diseases. Antioxidant treatment have been pointed out to be an encouraging palliative treatment; the beneficial effects documented involve slowing the progression of the disease, a reduction of cell degeneration, and improvement of retinal functions. There is a vast information corpus on antioxidant candidates. In this review, we expose three of the main antioxidant treatments, selected for their promising results that has been reported to date. Recently, the sulforaphane, an isothiocyanate molecule, has been unveiled as a neuroprotective candidate, by its antioxidant properties. Progesterone, a neurosteroid has been proposed to be a solid and effective neuroprotective agent. Finally, the lipoic acid, an organosulfur compound, is a well-recognized antioxidant. All of them, have been tested and studied on different retinal disease models. In this review, we summarized the published results of these works, to offer a general view of the current antioxidant treatment advances, including the main effects and mechanisms described.
Databáze: OpenAIRE